We plan to conduct future studies that investigate the use of these CGRP analogs in the treatment of cardiovascular diseases in our TAC model and others that reflect sex differences in clinical presentation and thoroughly investigate the interaction of sex hormones with CGRP. Here, CALCA is linked to cardiovascular disorder.